A Sixty and Me contributor suggests reviewing last week’s activities to spot what brings joy and what may be crowding it out in retirement.

A UC Santa Cruz commentary argues that P3, a peptide long considered harmless, can form aggregates and may contribute to Alzheimer’s-related damage.

A cholesterol drug lowered an Alzheimer’s blood biomarker in an ApoE4 subgroup, but evidence that cholesterol treatment prevents or treats dementia remains unproven.

A 36-person randomized trial linked N-acetylcysteine to brain imaging changes and self-reported symptom improvements in people with multiple sclerosis.

A Chalmers-led study links protein patterns in TRL and Lp(a) particles to biological processes that may help explain heart disease risk beyond LDL.